Take Your Trading To The Next Level. Get Started Here!

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

July 2, 2024 Comments Off

It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year.